Literature DB >> 7704490

Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery.

B McCormack1, G Gregoriadis.   

Abstract

A novel concept in drug delivery discussed here, takes advantage of certain properties of the drug "containers" cyclodextrins and liposomes to combine them into a single system thus circumventing problems associated with both systems. The concept, entailing entrapment of water-soluble cyclodextrin-drug inclusion complexes in liposomes, would allow accommodation of insoluble drugs in the aqueous phase of vesicles. This would potentially increase the drug to lipid mass ratio to levels above those attained by conventional drug incorporation into the lipid phase, enlarge the range of insoluble drugs amenable to encapsulation to include, for instance, membrane destabilizing agents, allow targeting of complexes to specific sites and reduce toxicity. In the present work, soluble inclusion complexes of hydroxypropyl-beta-cyclodextrin with dehydroepiandrosterone, retinol and retinoic acid were prepared and entrapped into multilamellar liposomes by the dehydration-rehydration procedure. Complex-containing liposomes were then exposed to blood plasma. Results show that complex entrapment into liposomes depends on the lipid composition used. Nearly all of the cyclodextrin and considerable portions of the drugs were found to remain associated with the carrier in the presence of plasma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7704490     DOI: 10.3109/10611869408996821

Source DB:  PubMed          Journal:  J Drug Target        ISSN: 1026-7158            Impact factor:   5.121


  7 in total

1.  Cyclodextrin-mediated entrapment of curcuminoid 4-[3,5-bis(2-chlorobenzylidene-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats.

Authors:  Hrushikesh Agashe; Kaustuv Sahoo; Pallavi Lagisetty; Vibhudutta Awasthi
Journal:  Colloids Surf B Biointerfaces       Date:  2011-01-25       Impact factor: 5.268

Review 2.  Cyclodextrins in drug delivery: an updated review.

Authors:  Rajeswari Challa; Alka Ahuja; Javed Ali; R K Khar
Journal:  AAPS PharmSciTech       Date:  2005-10-14       Impact factor: 3.246

3.  Liposome-encapsulated EF24-HPβCD inclusion complex: a preformulation study and biodistribution in a rat model.

Authors:  H Agashe; P Lagisetty; K Sahoo; D Bourne; B Grady; V Awasthi
Journal:  J Nanopart Res       Date:  2011-06-01       Impact factor: 2.253

4.  Effect of cyclodextrin complexation on the liposome permeability of a model hydrophobic weak Acid.

Authors:  Vijay Joguparthi; Bradley D Anderson
Journal:  Pharm Res       Date:  2008-07-19       Impact factor: 4.200

5.  Development and evaluation of inhalational liposomal system of budesonide for better management of asthma.

Authors:  J J Parmar; D J Singh; Darshana D Hegde; A A Lohade; P S Soni; A Samad; Mala D Menon
Journal:  Indian J Pharm Sci       Date:  2010-07       Impact factor: 0.975

6.  Inhalational system for Etoposide liposomes: formulation development and in vitro deposition.

Authors:  J J Parmar; D J Singh; A A Lohade; Darshana D Hegde; P S Soni; A Samad; Mala D Menon
Journal:  Indian J Pharm Sci       Date:  2011-11       Impact factor: 0.975

7.  Temoporfin-in-Cyclodextrin-in-Liposome-A New Approach for Anticancer Drug Delivery: The Optimization of Composition.

Authors:  Ilya Yakavets; Henri-Pierre Lassalle; Dietrich Scheglmann; Arno Wiehe; Vladimir Zorin; Lina Bezdetnaya
Journal:  Nanomaterials (Basel)       Date:  2018-10-18       Impact factor: 5.076

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.